
BeiGene, Ltd. BGNE
$ 184.71
0.49%
Quarterly report 2024-Q3
added 11-12-2024
Country |
![]() |
IPO year |
2016 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. John V. Oyler |
Employees in the company |
4 600 |
Shares |
1.36 B |
Market Cap[1] |
$ 251 B |
EBITDA (LTM) |
$ -484 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.